Gilder Gagnon Howe & CO LLC Zoetis Inc. Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 30, 2018	SELL	$83.5 - $93.23 $262,106 - $292,648	-3,139 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$79.9 - $89.2 $178,336 - $199,094	-2,232 Reduced 41.56%	3,139 $267,000
Q1 2018 Apr 30, 2018	BUY	$71.51 - $84.69 $110,482 - $130,846	1,545 Added 40.38%	5,371 $449,000
Q4 2017 Jan 31, 2018	SELL	$63.24 - $72.8 $250,999 - $288,943	-3,969 Reduced 50.92%	3,826 $276,000
Q3 2017 Nov 06, 2017	BUY	$59.73 - $65.4 $465,595 - $509,793	7,795	7,795 $497,000

1,956

412M

1.02M

1.09M

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.